→ Live Video Dermatology Consults
→ Board Certified Dermatologist
→ Expert diagnosis via videoconference
→ Rx sent to your pharmacy
→ Covered by Medicare and most commercial insurances
→ Affordable; HSA/FSA eligible
→ Comfort and safety from your own home
VIRTUAL DERMATOLOGY VISITS ANYTIME, ANYWHERE
Convenience and safety of our patients and employees are of the utmost importance to us. In order to flatten the curve, promote social distancing, and keep patients from potentially getting exposed to COVID-19 in Urgent Care Centers and Emergency Rooms, we now offer telehealth options. In most instances, a virtual visit with a board-certified dermatologist can be scheduled in less than 24 hours.
WHAT IS TELEDERMATOLOGY?
Virtual dermatology visit, also known as teledermatology, is offered to established as well as new patients, to have dermatology visits from the comfort and safety of their home, without the wait, delay, or risk of exposure. This service gives patients access to a board-certified dermatologist through a secure website or mobile device. You can schedule online in a few minutes with a few clicks or phone call. Patients receive a full consultation, complete with diagnosis, personalized treatment plan, and prescriptions sent to the pharmacy of their choice.
WILL I SEE A DOCTOR DURING MY TELEDERMATOLOGY CONSULTATION?
You will see a board-certified dermatologist for your initial as well as any follow-up virtual visits. A dermatologist has extensive training in the diagnosis and treatment of conditions of skin, hair, and nails, which they acquire during three years of dermatology residency training. A board-certified dermatologist has acquired certification status from the American Board of Dermatology after successfully completing all certification requirements including demonstration of their knowledge as well as diagnostic and therapeutic skills.
WHAT CONDITIONS CAN BE TREATED BY A TELEDERMATOLOGY VISIT?
Dermatologists can diagnose and treat and more than 3000 conditions of skin, hair, and nails. The majority of them can be diagnosed and treated via a teledermatology visit, including acne, eczema, dry skin, discoloration, changing moles, skin infections, shingles, warts, cold sores, yeast infections, psoriasis, rashes, allergic reactions, vitiligo, hair loss, melasma, nail changes, poison ivy rash, and more. If an in-office diagnostic or therapeutic option is needed, the doctor will advise you accordingly. For life-threatening conditions, please call 911 or visit the local Emergency Room.
HOW MUCH DOES A TELEHEALTH VISIT COST? DOES MY INSURANCE COVER THE COST?
Telehealth visits are covered benefits for Medicare beneficiaries as well as many commercial insurances, especially in the light of COVID-19 pandemic, subject to copayments, coinsurances, and deductibles. We accept most insurance plans and can bill your telehealth visit with your insurance career. Your normal co-pay, coinsurance and/or deductible will be collected prior to your virtual visit.
WILL MY INFORMATION BE KEPT PRIVATE AND CONFIDENTIAL?
Yes! Telehealth visits are subject to the same standard of care as in-office visits, including HIPPA provisions, and we take patient privacy and confidentiality very seriously. Patient photos, personal and medical information, videoconference, diagnoses, and treatments are never shared with anyone without explicit written authorization from the patient.
Dr. Amin is a board-certified dermatologist, and a fellow of American Academy of Dermatology. She is a published author, invited speaker, and awardee of several scholarships and national awards for her contribution to research.
While treating all ages and skin types, Dr. Amin is committed to delivering personalized, affordable and compassionate care. She has consistently earned the trust and confidence of her patients and referring doctors and thoroughly enjoys the ongoing relationships with her patients and their families. She has been recognized continually as one of DFW’s best dermatologists by local magazines like D Magazine, Fort Worth Magazine and Texas Monthly Magazine.
BS
Loyola University Chicago
MD
University of Illinois at Chicago
PhD
University of Illinois at Chicago
INTERNSHIP
San Francis Presence Hospital Chicago
DERMATOLOGY RESIDENCY
University of Minnesota
Mushtaq, S., Terzi, E., Recalcati, S., Salas-Alanis, J., Amin, S. A. & Faizi, Nafis (2020) Cutaneous adverse effects duer to personal protective measures during COVID-19 pandemic: A study of 101 patients. Submitted.
Amin, S. A., Lin, Z., Innes, J., Kim, J. J. & Bulun, S. E. IL-1β inhibits differentiation of breast adipose fibroblasts. Unpublished manuscript.
Amin, S. A., Lin, Z., Yin, P., Innes, J., Kim, J. J. & Bulun, S. E. Malignant epithelial IL-1β mediates PGE2 secretion from adipose fibroblasts in breast cancer. Unpublished manuscript.
Amin, S. A., Lin, Z., Chen, Y. H., Zhao, H., Kim, J. J. & Bulun, S. E. Prostaglandin E2 mediated mPGES-1 induction occurs via NF-κB pathway in breast adipose fibroblasts. Unpublished manuscript.
Chen, L., Lin, S.X., Amin, S., Overbergh, L., Maggiolino, G. & Chan, L.S. (2010) VCAM-1 blockade delaysdisease onset reduces disease severity and inflammatory cells in an atopic dermatitis model. Immunol Cell Biol, 88, 334-42.
Bulun S.E., Lin, Z., Zhao, H., Lu, M., Amin, S., Reierstad, S., & Chen, D. (2009) Regulation of aromatase expression in breast cancer tissue. Ann N Y Acad Sc, 1155, 121-131.
Bulun, S.E., Chen, D., Lu, M., Zhao, H., Cheng, Y., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., Su, E., Marsh, E., Hakim, A., Yin, P., Ishikawa, H., Amin, S.A., Imir, G., Gurates, B., Attar, E., Reierstad, S., Innes, J., & Lin, Z. (2007) Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol, 106, 81-96.
Amin, S. A., Huang, C. C., Reierstad, S., Lin, Z., Arbieva, Z., Wiley, E., Saborian, H., Haynes, B., Cotterill, H., Dowsett, M. & Bulun, S. E. (2006) Paracrine-stimulated gene expression profile favors estradiol production in breast tumors. Mol Cell Endocrinol, 253, 44-55.
Deb, S., Zhou, J., Amin, S. A., Imir, A. G., Yilmaz, M. B., Lin, Z. & Bulun, S. E. (2006) A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts. J Biol Chem, 281, 2585-97.
Bulun, S. E., Lin, Z., Imir, G., Amin, S. A., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., Gurates, B., Tamura, M., Langoi, D. & Deb, S. (2005) Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev, 57, 359-83.
Deb, S., Amin, S. A., Imir, A. G., Yilmaz, M. B., Suzuki, T., Sasano, H. & Bulun, S. E. (2004) Estrogen regulates expression of tumor necrosis factor receptors in breast adipose fibroblasts. J Clin Endocrinol Metab, 89, 4018-24.
Bulun, S. E., Fang, Z., Imir, G., Gurates, B., Tamura, M., Yilmaz, B., Langoi, D., Amin, S. A., Yang, S. & Deb, S. (2004) Aromatase and endometriosis. Semin Reprod Med, 22, 45-50.
Gurates, B., Amsterdam, A., Tamura, M., Yang, S., Zhou, J., Fang, Z., Amin, S. A., Sebastian, S. & Bulun, S.E. (2003) WT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells. Mol Cell Endocrinol, 208, 61-75.
Bulun S.E., Gurates, B., Fang, Z., Mitsutoshi, T., Langoi, D., Imir, G., Amin, S.A., Deb, S., and Yang, S (2003) Treatment with Aromatase Inhibitors. Tulandi, T and Redwine, D, editors. In: Endometriosis: Advances and Controversies, 189-202.
Bulun, S.E., Gurates, B., Fang, Z., Tamura, M., Sebastian, S., Zhou, J., Amin, S. A., & Yang, S. (2002) Mechanisms of excessive estrogen formation in endometriosis. J Reprod Immunol, 55, 21-33.
WebMD – COVID – 19 and Skin Constions: What We Know So Far
NBC- Rashes Might Be New COVID – 19 Symptoms
Skin Secrets from a Dermatologist
“Winter Skin Damage” Live interview on “Fox Buzz” on Fox9 KMSP Studios
“Ditch the Sunscreen” Live interview on “Fox Buzz” on Fox9 KMSP Studios
Editorial Reviewer, JAAD Case Reports 2019- present
Editorial Reviewer, Journal of American Academy of Dermatology 2018-present
“Comparative Review of Safety and Efficacy of Biologics Approved for Psoriasis” Medical Dermatology Society Annual Meeting 2018.
Minnesota Dermatology Society Meeting case presentations 2010-2013.
Diabetes and Diabetic Foot Ulcers, St Francis Hospital, Evanston, IL 2009.
National Student Research Forum, UTMB, Galveston, TX 2005, 2006.
Clinical Preceptor for pre-health students from community high schools, colleges and medical schools 2018-2020.
Spot Me, American Academy of Dermatology Annual Skin Cancer Screenings 2013-present.
Swim Across America Volunteer dermatologist 2017-2018.
Resident Volunteer, Philips Neighborhood Clinic and Uptown Clinic, Dermatology Clinic, Minneapolis, MN 2010-2013
Book Reviewer, McGraw-Hill Medical Publishing Division, New York, NY 2005-2007
Judge, University of Illinois at Chicago, Student Research Symposium 2006
Judge, Chicago Public School Annual Science Fair, Chicago Public Schools 1996-1999
Dermatology Solutions is located in Grapevine, TX and Argyle, TX to serve patients in Grapevine, Southlake,
Westlake, Trophy Club, Roanoke, Argyle, Denton, Lantana, Corinth, Flower Mound, Lewisville, Highland Village, Decatur and surrounding areas.
Dermatology Solutions Grapevine
1600 W College Street, LL40,
Grapevine, TX 76051
7226 Crawford Road, Suite 100,
Argyle, TX 76226
Copyright © 2021 Dermatology Solutions.